Hygeia Healthcare Holdings Co., Limited (Hygeia Health) filed a Next Day Disclosure Return after repurchasing 181,400 ordinary shares on 19 May 2026. The shares were bought on the Hong Kong Stock Exchange at prices ranging from HKD 10.95 to HKD 11.07, translating to a volume-weighted average of approximately HKD 11.02 per share and a total consideration of HKD 2.00 million.

Following the transaction, the company’s issued share count (excluding treasury shares) dropped by 0.03% to 612.97 million. Treasury shares rose to 5.53 million, while the total issued share capital remained unchanged at 618.50 million.

The purchase was executed under the buy-back mandate approved on 27 June 2025, which permits the repurchase of up to 61.85 million shares. To date, 5.53 million shares—equivalent to 0.89% of the issued shares at the time the mandate was granted—have been bought back. All newly repurchased shares are being held as treasury stock, and the company is subject to a moratorium on issuing new shares or selling treasury shares until 18 June 2026.